Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer

Anthracyclines, such as doxorubicin, are used as first-line chemotherapeutics, usually in combination therapies, for the treatment of advanced breast cancer. While these drugs have been successful therapeutic options, their use is limited due to serious drug related toxicities and acquired tumor res...

Full description

Saved in:

Bibliographic Details
Published in:	Translational oncology Vol. 11; no. 4; pp. 988 - 998
Main Authors:	Hasim, Mohamed S., Nessim, Carolyn, Villeneuve, Patrick J., Vanderhyden, Barbara C., Dimitroulakos, Jim
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.08.2018 Elsevier
ISSN:	1936-5233, 1936-5233
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!